Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression [Phase 1, Phase 2]
Clinical trial update for BT5528-100 (Phase 1/2) in EphA2-expressing advanced solid tumors. The study includes urothelial carcinoma, ovarian…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial of SOT102 antibody-drug conjugate in advanced gastric and pancreatic adenocarcinoma has been terminated; results ha…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 [Phase 1]
A Phase 1 study of EO-3021 in adults with CLDN18.2-expressing solid tumors was terminated; results have been posted.
-
FDA approval · 2025-11-12FDA Tentative Approval: FLUOROURACIL — Supplemental Application (Gland Pharma Limited)
FDA Tentative Approval for Fluorouracil from Gland Pharma Limited under an ANDA, indicating a pathway to U.S. market subject to regulatory t…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases [Phase 1]
This is a Phase 1 clinical trial evaluating nab-paclitaxel in combination with paclitaxel and ramucirumab for clinical stage IVB gastric can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: The Gastric Cancer Foundation: A Gastric Cancer Registry
Registry-based clinical trial for a gastric cancer registry sponsored by The Gastric Cancer Foundation; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) [Phase 1, Phase 2]
Spevatamig (PT886) is being studied as a monotherapy or in combination with chemotherapy and/or immune checkpoint inhibitors in Phase 1/2 tr…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Avutometinib and Defactinib in Diffuse Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of Avutometinib and Defactinib for diffuse gastric cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours [Phase 2]
Phase 2 clinical trial of crizotinib completed in invasive lobular breast cancer, gastric cancer, and triple-negative breast cancer populati…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers [Phase 1, Phase 2]
A Phase 1/2 trial update for Vorbipiprant (CR6086) combined with Balstilimab (AGEN2034) in stage IV refractory pMMR-MSS colorectal cancer an…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients [Phase 1]
A Phase 1 clinical trial evaluating the combination of neratinib and fam-trastuzumab deruxtecan for advanced gastric and gastroesophageal ca…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Adaptive Radiation for Abdominopelvic Metastases [Phase 1]
Phase 1 trial evaluating adaptive radiation therapy for abdominopelvic metastases is currently recruiting, including cases of pelvic soft ti…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Clinical trial SYNERGY-AI is an AI-based precision oncology matching and registry study sponsored by Massive Bio, currently recruiting acros…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the diagnostic performance of GEH300079 (68Ga) PET/CT for detecting pancreatic cancer in patients with colorect…
-
EMA approval · 2025-10-20EMA Authorised: Herwenda (trastuzumab) — Sandoz GmbH
EMA authorised Herwenda, a trastuzumab biosimilar by Sandoz GmbH, for certain HER2-positive cancers. Approved indications include breast can…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers [Phase 1]
A Phase 1 study of AMG 199 in MUC17-positive solid tumors including gastric, gastroesophageal junction, colorectal, and pancreatic cancers h…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer [NA]
This trial update describes the effects of zinc supplementation on quality of life in patients with gastrointestinal cancers. The study has …
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer [Phase 2]
Phase 2 study of DKN-01 in combination with tislelizumab, with or without chemotherapy, in gastric and gastroesophageal cancers was terminat…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer [Phase 1, Phase 2]
Clinical trial update on AZD7789 evaluating safety and efficacy in participants with advanced or metastatic solid cancers in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study [NA]
A population-based study in Bhutan investigates Helicobacter pylori infection and related gastric diseases in the community.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Epidemiology and Treatment of Gastric Cancer
A completed clinical trial update on the epidemiology and treatment of gastric cancer, with attention to sex differences.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Futibatinib in Patients With Specific FGFR Aberrations [Phase 2]
Taiho Oncology reports a Phase 2 trial of futibatinib in patients with FGFR aberrations across advanced cancers. The study (NCT04189445) was…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
This clinical trial update describes a study evaluating detection of tumor cells and tumor DNA in blood, urine, and bone marrow across multi…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial [Phase 2]
A Phase 2 randomized trial is evaluating the safety and efficacy of RAK Cell Therapy in late-stage gastric cancer. Recruitment is ongoing.